Pharmafile Logo

Boosting Memory with Frequent Virtual Touchpoints – Perks of Virtual Medical Education

August 15, 2024 |  

Unlock the secrets to effective learning with our latest video! Learn how frequent, short virtual sessions utilize the Recency Effect to improve memorization and avoid fatigue, outperforming long, one-time meetings. Dive into the benefits of micro-learning for medical education:

Explore how frequent virtual touchpoints can significantly enhance memory retention and reduce mental fatigue in our sixth video from the “Perks of Virtual Medical Education” series. Learn why this method is more effective than traditional long meetings.

6. Short but Frequent Virtual Touchpoints Enhance Long-Term Memorization Research has shown that shorter, more frequent virtual interactions are far superior to lengthy, one-off meetings for improving knowledge retention and work performance. This approach leverages the “Recency Effect,” where individuals remember recently presented information more vividly. Without frequent review, memory recall diminishes significantly over time—a problem mitigated by regular virtual touchpoints that reintroduce information, allowing it to transition from short-term to long-term memory effectively. By integrating these frequent, micro-learning sessions, participants not only avoid mental fatigue but also retain a greater portion of the information, making these sessions crucial for continuous professional development.

Discover more about the science behind memory retention and how virtual collaboration tools can transform learning and retention in medical education on our blog: https://www.impetusdigital.com/2020/09/17/top-10-reasons-why-virtual-collaboration-and-medical-education-will-persist-in-the-new-normal/

Enhance your virtual engagements with Impetus Digital:

Stay connected for the latest in virtual medical education:

This content was provided by Impetus Digital

Company Details

 Latest Content from  Impetus Digital 

Beat inflation with virtual meetings and programs

At the time of writing, the average inflation rate worldwide sits at 7.4%, the highest it’s been for decades. Here in Canada, the inflation rate is not forecasted to come back down...

Engaging KOLs & Gaining Insights in Pharma’s New Normal

Kaitlin Anstett, Senior Medical Advisor at Theratechnologies, shares her unique insights into the way Medical Affairs teams are changing the way they are engaging and interacting with their most important...

There’s No Going Back: How COVID-19 will Change Pharma Forever

Munther Baara, VP Product Strategy and Innovation at EDETEK, discusses all things clinical trials. Especially, we discuss the current gaps and the impact of COVID-19 on the way Pharma approaches...

Powering Rapid Cognitive Analysis with AI

Dr. Tom Sawyer, CFO at Cognetivity Neurosciences, discusses the benefits of AI-driven dementia detection technology for patients, health care providers, and clinical research.

KOL Ambassador Program & Podcast Creation: A Customer Story

Leveraging Impetus Digital’s best-in-class synchronous (real-time) and asynchronous (over-time, anytime) tools, our client facilitated a virtual ambassador program with three oncologist key opinion leaders (KOLs) from South Korea.The client’s main objectives...

Importance of Emotional Intelligence in Pharma and Medical Affairs

Emma Lynch, Founder of EQ Vibration & Quadrant 2 Medical, explores a number of interesting topics related to Medical Affairs. Among many other things, she discusses the importance of emotional...

Virtual product launch planning: the ultimate playbook

We walk you through, step-by-step, how cross-functional teams can seamlessly work together and overcome the many obstacles associated with traditional product launches.

Artificial Intelligence for Identifying and Monitoring Cognitive Decline

Liam Kaufman, CEO & Co-founder of Winterlight Labs, explores a range of topics related to AI, machine learning, natural language processing, digital biomarkers, and human-computer interactions in healthcare.

Trust and transparency in Pharma & healthcare: impact of the COVID-19 pandemic

While it is obvious that trust in life science and healthcare companies is suboptimal, exactly how to improve the public’s trust is unclear...